One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Haemodiafiltration for all: are we CONVINCEd?
Rukshana Shroff 1 , Carlo Basile 2 , Frank van der Sande 3 and Sandip Mitra 4 ; on behalf of the EuDial Working Group†of the European Renal Association
doi : 10.1093/ndt/gfad136
Volume 38, Issue 12, December 2023
Hope or hype? Clinicians’ dilemma in the era of ever-expanding antigens in membranous nephropathy
Marco Bonilla1 , Mohamed Hassanein2 , Tiffany Caza3 and Kenar D. Jhaveri
doi : 10.1093/ndt/gfad162
Sodium–glucose co-transporter-2 inhibitor use and erythrocytosis: assessment of risk and need for referral to haematology
Naseema Gangat and Ayalew Tefferi
doi : 10.1093/ndt/gfad171
The COVID-19 pandemic and mental health outcomes in CKD patients
Luuk B. Hilbrands
doi : 10.1093/ndt/gfad177
Intrauterine life to adulthood: a potential risk factor for chronic kidney disease
Mehmet Kanbay 1 , ?, Sidar Copur2 , Abdullah B. Yildiz2 , Andreea Covic3 , Adrian Covic3 , Paola Ciceri4 , Lorenza Magagnoli 4 and Mario Cozzolino
doi : 10.1093/ndt/gfad134
The complement system in IgAN: mechanistic context for therapeutic opportunities
Anna Duval 1 ,2 , Sophie Caillard2 and Véronique Frémeaux-Bacchi
doi : 10.1093/ndt/gfad140
Hypertension in chronic kidney disease—treatment standard 2023
Panagiotis I. Georgianos1 and Rajiv Agarwal
doi : 10.1093/ndt/gfad118
Reserved gait capacity and mortality among patients undergoing hemodialysis
Shun Yoshikoshi 1 ,2 , Shohei Yamamoto3 , Yuta Suzuki4 , Keigo Imamura1 ,5 , Manae Harada2 , Kentaro Kamiya1 and Atsuhiko Matsunaga
doi : 10.1093/ndt/gfad109
Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
Takeshi Hasegawa 1 ,2 ,3 ,4 , Takahiro Imaizumi5 ,6 , Takayuki Hamano7 ,8 , Kenta Murotani9 , Naohiko Fujii10 , Hirotaka Komaba 11 , Masahiko Ando5 , Shoichi Maruyama 6 , Masaomi Nangaku 12 , Kosaku Nitta13 , Hideki Hirakata14 , Yoshitaka Isaka8 , Takashi Wada 15 and Masafumi Fukagawa 11 ; on behalf of the Chronic Kidney Disease Japan Cohort (CKD-JAC) Study Group
doi : 10.1093/ndt/gfad096
Urinary albumin excretion and cancer risk: the PREVEND cohort study
Li Luo 1 ,†, Lyanne M. Kieneker1 ,†, Bert van der Vegt2 , Stephan J.L. Bakker1 , Eke G. Gruppen1 , Niek F. Casteleijn3 , Rudolf A. de Boer4 , Navin Suthahar 4 , Geertruida H. de Bock5 , Joseph Pierre Aboumsallem4 , Priya Vart 6 and Ron T. Gansevoort
doi : 10.1093/ndt/gfad107
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial
Hans-Joachim Anders 1 , Richard Furie2 , Ana Malvar3 , Ming-Hui Zhao4 , Keiju Hiromura5 , Julia Weinmann-Menke 6 , Yulia Green7 , Angela Jones-Leone8 , Daniela Negrini9 ,†, Roger A. Levy8 , Liz Lightstone10 , Yoshiya Tanaka 11 and Brad H. Rovin
doi : 10.1093/ndt/gfad167
Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study
Yu Ho Lee1 , Sang Heon Song2 , Seung Hwan Song3 , Ho Sik Shin4 , Jaeseok Yang 5 , Myoung Soo Kim6 and Hyeon Seok Hwang7 ; the KOTRY Study Group
doi : 10.1093/ndt/gfad115
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease
Zhenhong Guo1 ,2 , Feifei Zhong1 , Meng Hou3 , Jinlan Xie1 , A. Zhong Zhang4 , Xinran Li1 , Yuan Li1 , Baocheng Chang 1 and Juhong Yang
doi : 10.1093/ndt/gfad173
Plasma arginine metabolites in health and chronic kidney disease
Amy Y.M. Au1 ,2 ,†, Kevin Mantik3 ,†, Forough Bahadory3 , Paul Stathakis3 , Hayley Guiney4 , Jonathan Erlich1 ,2 , Robert Walker5 , Richie Poulton4 , Andrea Rita Horvath3 and Zoltan H. Endre
doi : 10.1093/ndt/gfad108
Chronic kidney disease is a key risk factor for aortic stenosis progression
Alexandre Candellier1 ,2 ,†, Yohann Bohbot2 ,3 ,†, Agnes Pasquet4 ,5 , Momar Diouf6 , Emmanuelle Vermes3 , Eric Goffin4 ,7 , Mesut Gun3 ,6 , Fanny Peugnet3 , Lucie Hénaut2 , Dan Rusinaru2 ,3 , Romuald Mentaverri2 ,8 , Saïd Kamel2 ,8 , Gabriel Choukroun1 ,2 , Jean-Louis Vanoverschelde4 ,5 and Christophe Tribouilloy
doi : 10.1093/ndt/gfad116
Automated evaluation with deep learning of total interstitial inflammation and peritubular capillaritis on kidney biopsies
Amélie Jacq1 , Georges Tarris2 , Adrien Jaugey3 ,4 , Michel Paindavoine4 , Elise Maréchal1 , Patrick Bard3 ,4 , Jean-Michel Rebibou1 ,5 , Manon Ansart3 ,4 , Doris Calmo6 , Jamal Bamoulid5 ,6 , Claire Tinel1 , Didier Ducloux5 ,6 , Thomas Crepin5 ,6 , Melchior Chabannes5 ,6 , Mathilde Funes de la Vega2 , Sophie Felix7 , Laurent Martin2 and Mathieu Legendre
doi : 10.1093/ndt/gfad094
Cumulative smoking dose is associated with subclinical renal injury: a pathological study in individuals without chronic kidney disease
Eri Ataka1 , Yuta Matsukuma1 , Kenji Ueki1 , Akihiro Tsuchimoto1 , Yasuhiro Okabe2 , Kosuke Masutani3 , Masafumi Nakamura2 , Toshiaki Nakano 1 ,4 and Takanari Kitazono
doi : 10.1093/ndt/gfad124
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study
Sarah J. Schrauben1 ,2 , Hima Sapa3 , Dawei Xie2 , Xiaoming Zhang2 , Amanda Hyre Anderson2 ,4 , Michael G. Shlipak5 , Chi-yuan Hsu6 , Tariq Shafi7 , Rupal Mehta8 , Zeenat Bhat9 , Julie Brown10 , Jeanne Charleston11 , Jing Chen12 , Jiang He 12 , Joachim H. Ix13 , Pandurango Rao14 , Ray Townsend1 , Paul L. Kimmel15 , Ramachandran S. Vasan16 , Harold I. Feldman1 ,17 , Jesse C. Seegmiller18 , Henri Brunengraber19 , Thomas H. Hostetter20 and Jeffrey R. Schelling 21 ; on behalf of the CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
doi : 10.1093/ndt/gfad103
Long-term effect of COVID-19 infection on kidney function among COVID-19 patients followed in post-COVID-19 recovery clinics in British Columbia, Canada
Mohammad Atiquzzaman 1 ,2 , Jordyn R. Thompson2 , Selena Shao1 , Ognjenka Djurdjev1 ,3 , Micheli Bevilacqua2 , Michelle M.Y. Wong2 , Adeera Levin1 ,2 and Peter C. Birks
doi : 10.1093/ndt/gfad121
Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy
Bj?rn Peters1 ,2 , Joachim Beige3 ,4 , Justyna Siwy5 , Michael Rudnicki6 , Ralph Wendt7 , Alberto Ortiz 8 , Ana Belen Sanz8 , Harald Mischak5 , Heather N. Reich9 ,10 , Salmir Nasic1 ,11 , Dana Mahmood12 , Anders Persson13 , Anders Fernstr?m14 , Maria Weiner14 , Bernd Stegmayr15 and on behalf of the PersTIgAN Working Group
doi : 10.1093/ndt/gfad125
Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH)
Pantelis A. Sarafidis 1 , Marieta Theodorakopoulou 1 , Alberto Ortiz 2 , Beatriz Fernandez-Fern?ndez2 , Ionut Nistor3 ,4 , Roland Schmieder5 , Mustafa Arici6 , Athanasios Saratzis7 , Patricia Van der Niepen 8 , Jean-Michel Halimi9 , Reinhold Kreutz10 , Andrzej Januszewicz11 , Alexandre Persu12 ,†and Mario Cozzolino
doi : 10.1093/ndt/gfad095
Plasma cell–directed therapy for rituximab-refractory PLA2R+ membranous nephropathy
Sofiane Salhi1 , David Ribes1 , Françoise Fortenfant2 and Stanislas Faguer
doi : 10.1093/ndt/gfad135
Memory B cells predict outcome in primary podocytopathies of adults
Joyita Bharati1 ,2 , Jhumki Das3 , Pandiarajan Vignesh3 , Kenar D. Jhaveri 2 , Arun Prabhahar1 , Chandan Krushna Das4 ,5 , Anita Singh Parihar6 , Ritambhra Nada7 , Raja Ramachandran 1 , Amit Rawat 3 and Harbir Singh Kohli1
doi : 10.1093/ndt/gfad157
Correction to: Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020
doi : 10.1093/ndt/gfad204
